Benitec Biopharma Inc (BNTC)
6.99
-0.06
(-0.85%)
USD |
NASDAQ |
Jun 28, 16:00
7.00
+0.01
(+0.14%)
After-Hours: 20:00
Benitec Biopharma Net Income (Annual): -19.56M for June 30, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
Date | Value |
---|---|
June 30, 2023 | -19.56M |
June 30, 2022 | -18.21M |
June 30, 2021 | -13.88M |
June 30, 2020 | -8.274M |
June 30, 2019 | 2.609M |
June 30, 2018 | -8.551M |
Date | Value |
---|---|
June 30, 2017 | -4.372M |
June 30, 2016 | -18.50M |
June 30, 2015 | -8.827M |
June 30, 2014 | -10.84M |
June 30, 2013 | -6.424M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-19.56M
Minimum
2023
2.609M
Maximum
2019
-11.46M
Average
-13.88M
Median
2021
Net Income (Annual) Benchmarks
Abbott Laboratories | 5.723B |
Intuitive Surgical Inc | 1.798B |
Johnson & Johnson | 35.15B |
Galectin Therapeutics Inc | -41.07M |
TG Therapeutics Inc | 12.67M |